Literature DB >> 24813877

Quinazolines: new horizons in anticonvulsant therapy.

Vinod G Ugale1, Sanjay B Bari2.   

Abstract

The search for novel anticonvulsants with more selectivity and lower toxicity continues to be an area of intensive investigation in medicinal chemistry. The potency and selectivity in the pharmacological response of quinazolines as anticonvulsant have attracted the attention of many researchers to explore this framework for its potential. It is, therefore, topic of interest to study development of new synthetic strategies and their anticonvulsant potential based on the most recent knowledge emerging from the latest research. This review reports current progress in the area of new biologically active quinazoline scaffold as potent anticonvulsant. It is a sincere attempt to compile the synthetic and design aspects of quinazoline derivatives with significant anticonvulsant action. This structural class of compound can prove to be useful for the design and development of potent anticonvulsant agents.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticonvulsant; MES; PTZ-induced seizure; Synthesis quinazoline

Mesh:

Substances:

Year:  2014        PMID: 24813877     DOI: 10.1016/j.ejmech.2014.04.072

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  A ligand-based computational drug repurposing pipeline using KNIME and Programmatic Data Access: case studies for rare diseases and COVID-19.

Authors:  Alzbeta Tuerkova; Barbara Zdrazil
Journal:  J Cheminform       Date:  2020-11-25       Impact factor: 5.514

2.  Iodine/potassium iodide catalyst for the synthesis of trifluoromethylated quinazolines via intramolecular cyclization of 2,2,2-trifluoro-N-benzyl-N'-arylacetimidamides.

Authors:  Ali Darehkordi; Elham Kazemi
Journal:  Mol Divers       Date:  2019-03-13       Impact factor: 2.943

3.  Design, synthesis, and pharmacological evaluation of [1, 3] dioxolo-chromeno[2,3-b]pyridines as anti-seizure agents.

Authors:  Visarapu Malathi; Nissi Sharon; Pannala Padmaja; Deepak Lokwani; Saurabh Khadse; Prashant Chaudhari; Atul A Shirkhedkar; Pedavenkatagari Narayana Reddy; Vinod G Ugale
Journal:  Mol Divers       Date:  2022-10-10       Impact factor: 3.364

Review 4.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

5.  Hydrogen Transfer-Mediated Multicomponent Reaction for Direct Synthesis of Quinazolines by a Naphthyridine-Based Iridium Catalyst.

Authors:  Zhenda Tan; Zhongxin Fu; Jian Yang; Yang Wu; Liang Cao; Huanfeng Jiang; Juan Li; Min Zhang
Journal:  iScience       Date:  2020-03-21

6.  Antibacterial Effects of Quinazolin-4(3H)-One Functionalized-Conjugated Silver Nanoparticles.

Authors:  Abdulkader Masri; Ayaz Anwar; Naveed Ahmed Khan; Muhammad Saquib Shahbaz; Khalid Mohammed Khan; Syed Shahabuddin; Ruqaiyyah Siddiqui
Journal:  Antibiotics (Basel)       Date:  2019-10-09

7.  2-[(3-Aminoalkyl-(alkaryl-,aryl-))-1H-1,2,4-triazol-5-yl]anilines: synthesis and anticonvulsant activity.

Authors:  Yulya Martynenko; Galina Berest; Nina Bukhtiayrova; Igor Belenichev; Oleksiy Voskoboinik; Sergiy Kovalenko
Journal:  Turk J Chem       Date:  2020-06-01       Impact factor: 1.239

8.  2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis.

Authors:  Te-Sheng Chang; Chung-Kuang Lu; Yung-Yu Hsieh; Kuo-Liang Wei; Wei-Ming Chen; Sui-Yi Tung; Cheng-Shyong Wu; Michael W Y Chan; Ming-Ko Chiang
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

9.  Synthesis of some quinazolinones inspired from the natural alkaloid L-norephedrine as EGFR inhibitors and radiosensitizers.

Authors:  Mostafa M Ghorab; Maged S Abdel-Kader; Ali S Alqahtani; Aiten M Soliman
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

10.  Eco-friendly reactions in PEG-400: a highly efficient and green approach for stereoselective access to multisubstituted 3,4-dihydro-2(1H)-quinazolines using 2-aminobenzylamines.

Authors:  Nutan Sharma; Pankaj Sharma; Sunita Bhagat
Journal:  RSC Adv       Date:  2018-02-26       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.